Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance

June 1, 2011
DOI: 10.4016/30828.01
799 views
URL
Embed
Share

Please describe the reason for abuse:



Description:
In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr.... » More